CytomX Therapeutics Inc - CTMX - stock price prediction, stock price target, analyst ratings from 8 analysts

CytomX Therapeutics Inc has a share price target of US$ 12, revenue growth forecast of -53.1%, and profit growth estimate of -319.2% for FY26, based on top 8 analyst calls.